Josep Tabernero

6 ta ish

Hospital Quirónsalud Barcelona

1. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

   Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena +20

   MaqolaOAOchiq kirish20133 iqtibos

   ABIABI:AkademIndex/2026.other.098698

2. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

   Axel Grothey, Eric Van Cutsem, Alberto Sobrero +17

   Maqola20123 iqtibos

   ABIABI:AkademIndex/2026.other.241897

3. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

   Hans‐Joachim Schmoll, Eric Van Cutsem, Alexander Stein +34

   MaqolaOAOchiq kirish20122 iqtibos

   ABIABI:AkademIndex/2026.other.237708

4. Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer

   Susan Bullman, Chandra Sekhar Pedamallu, Ewa Sicińska +26

   Maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.339919

5. The landscape of somatic copy-number alteration across human cancers

   Rameen Beroukhim, Craig H. Mermel, Dale Porter +59

   Maqola20102 iqtibos

   ABIABI:AkademIndex/2026.other.839373

6. Enhancing global access to cancer medicines

   Javier Cortés, José Manuel Pérez-García, Antonio Llombart‐Cussac +13

   Sharh maqolaOAOchiq kirishEconomic and Financial Impacts of CancerCA A Cancer Journal for Clinicians20201 iqtibos

   ABIABI:AkademIndex/2026.other.000031